Drug Shortage Report for TEVA-SPIRONOLACTONE/HCTZ

Last updated on 2020-10-15 History
Report ID 123738
Drug Identification Number 00657182
Brand name TEVA-SPIRONOLACTONE/HCTZ
Common or Proper name SPIRONOLACTONE HCTZ 50/50MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SPIRONOLACTONE HYDROCHLOROTHIAZIDE
Strength(s) 50MG 50MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C03EA
ATC description DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-03
Estimated end date 2020-12-31
Actual end date
Shortage status Actual shortage
Updated date 2020-10-15
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-10-15 French Compare
v6 2020-10-15 English Compare
v5 2020-09-24 French Compare
v4 2020-09-24 English Compare
v3 2020-09-04 English Compare
v2 2020-09-03 French Compare
v1 2020-09-03 English Compare